Immunoglobulin γ chain allotypes and humoral immunity to HSV1 in Parkinson's disease

J Neuroimmunol. 2022 Oct 15:371:577948. doi: 10.1016/j.jneuroim.2022.577948. Epub 2022 Aug 6.

Abstract

The aim of this investigation was to determine if particular immunoglobulin GM (γ marker) alleles and genotypes were associated with Parkinson's disease (PD) and whether they contributed to the interindividual differences in the level of antibodies to herpes simplex virus type 1 (HSV1), which has been implicated in PD pathology. Using a case-control study design, 94 PD patients and 157 controls were characterized for anti-HSV1 IgG antibodies and genotyped for GM alleles expressed on IgG1 (3,17) and IgG2 (23 +, 23-). The homozygosity for the GM 3 and GM 23 alleles was significantly associated with susceptibility to PD (p = 0.004, 0.018, respectively). Also, GM 23 genotypes were significantly associated with anti-HSV1 IgG antibody levels in patients (p = 0.0021), but not in controls. These results suggest that GM genes may act as effect modifiers of the reported HSV1-PD association.

Keywords: GM allotypes; HSV1; Humoral immunity; Parkinson's disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Viral
  • Case-Control Studies
  • Herpesvirus 1, Human*
  • Humans
  • Immunity, Humoral
  • Immunoglobulin G
  • Immunoglobulin Gm Allotypes / genetics
  • Immunoglobulin gamma-Chains
  • Parkinson Disease* / genetics

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin Gm Allotypes
  • Immunoglobulin gamma-Chains